Summary
This prediction ended on 10.03.24 with a price of €9.67. The price of Altimmune has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.02%. HC_Wainwright has a follow-up prediction for Altimmune where he still thinks Altimmune is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altimmune | -4.137% | -4.137% | -28.724% | -14.693% |
| iShares Core DAX® | -2.680% | 4.261% | 2.121% | 57.510% |
| iShares Nasdaq 100 | 0.725% | 5.796% | 34.204% | 92.829% |
| iShares Nikkei 225® | -0.725% | 9.319% | 61.298% | 80.340% |
| iShares S&P 500 | 1.166% | 5.479% | 24.751% | 70.967% |
Comments by HC_Wainwright for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Ratings data for ALT provided by MarketBeat
In the thread Trading Altimmune
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten